UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Glycan analysis of erythropoiesis-stimulating agents

Journal of pharmaceutical and biomedical analysis, 2020-02, Vol.180, p.113031-113031, Article 113031

2020

Volltextzugriff (PDF)

Loss of muscarinic M4 receptors in hippocampus of Alzheimer patients

Brain research, 2003-01, Vol.960 (1-2), p.259-262

2003

Volltextzugriff (PDF)

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease : Clinical and Neurochemical Correlates

International journal of alzheimer's disease, 2011, Vol.2011 (2011), p.1-6

2011

Volltextzugriff (PDF)

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment

JAMA : the journal of the American Medical Association, 2009-07, Vol.302 (4), p.385

2009

Volltextzugriff (PDF)

CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study

Journal of neurology, neurosurgery and psychiatry, 2010-10, Vol.81 (10), p.1080-1086

2010

Volltextzugriff (PDF)

Inhibition of acetylcholine muscarinic M1 receptor function by the M1‐selective ligand muscarinic toxin 7 (MT‐7)

British journal of pharmacology, 2000-10, Vol.131 (3), p.447-452

2000

Volltextzugriff (PDF)

Identification of Novel α-Synuclein Isoforms in Human Brain Tissue by using an Online NanoLC-ESI-FTICR-MS Method

Neurochemical research, 2011-11, Vol.36 (11), p.2029-2042

2011

Volltextzugriff (PDF)

CSF amyloid beta 38 as a novel diagnostic marker for dementia with Lewy bodies

Journal of neurology, neurosurgery and psychiatry, 2011, Vol.82 (2), p.160-164

2011

Volltextzugriff (PDF)

CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies

Journal of neurology, neurosurgery and psychiatry, 2011-02, Vol.82 (2), p.160-164

2011

Volltextzugriff (PDF)

Inhibition of acetylcholine muscarinic M 1 receptor function by the M 1 ‐selective ligand muscarinic toxin 7 (MT‐7)

British journal of pharmacology, 2009-01, Vol.131 (3), p.447-452

2009

Volltextzugriff (PDF)

The first World Health Organization International Standard for infliximab products: A step towards maintaining harmonized biological activity

mAbs, 2019-01, Vol.11 (1), p.13-25

2019

Volltextzugriff (PDF)

Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease

Dementia and geriatric cognitive disorders, 2008-01, Vol.25 (6), p.559-563

2008

Volltextzugriff (PDF)

Dynamin protein in stroke and vascular dementia

Neuroscience letters, 2014-03, Vol.563, p.118-122

2014

Volltextzugriff (PDF)

Loss of muscarinic M 4 receptors in hippocampus of Alzheimer patients

Brain research, 2003-01, Vol.960 (1), p.259-262

2003

Volltextzugriff (PDF)

Snake toxins with high selectivity for subtypes of muscarinic acetylcholine receptors

Biochimie, 2000-09, Vol.82 (9-10), p.793

2000

Volltextzugriff (PDF)

P2‐052: sAPP‐α and sApp‐β levels in Alzheimer's disease, Lewy body and Parkinson's disease dementia patients and their correlation with clinical diagnosis

Alzheimer's & dementia, 2011-07, Vol.7 (4S_Part_9), p.S324-S324

2011

Volltextzugriff (PDF)

sAPP-α and sApp-β levels in Alzheimer's disease, Lewy body and Parkinson's disease dementia patients and their correlation with clinical diagnosis

Alzheimer's & dementia, 2011-07, Vol.7 (4), p.S324-S324

2011

Volltextzugriff (PDF)

CSF amyloid 38 as a novel diagnostic marker for dementia with Lewy bodies

Journal of neurology, neurosurgery and psychiatry, 2011-02, Vol.82 (2), p.160-164

2011

Volltextzugriff (PDF)

Inflammatory mediators in the frontal lobe of patients with mixed and vascular dementia

Dementia and geriatric cognitive disorders, 2008-03, Vol.25 (3), p.278-286

2008

Volltextzugriff (PDF)

CSF amyloid- and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study

Journal of neurology, neurosurgery and psychiatry, 2010-10, Vol.81 (10), p.1080-1086

2010

Volltextzugriff (PDF)

Identification of Novel [alpha]-Synuclein Isoforms in Human Brain Tissue by using an Online NanoLC-ESI-FTICR-MS Method

Neurochemical research, 2011-11, Vol.36 (11), p.2029

2011

Volltextzugriff (PDF)

Biomarkers in spinal fluid of patients with dementia

Tidsskrift for den Norske Lægeforening, 2011-11, Vol.131 (22), p.2235-2238

2011

Volltextzugriff (PDF)

Biomarkører i spinalvæske ved demens

Tidsskrift for den Norske Lægeforening, 2011, Vol.131 (22), p.2235-2238

2011

Volltextzugriff (PDF)

P1‐049: Hippocampal atrophy and lateral ventricle enlargement in Parkinson's disease subjects with mild cognitive impairment

Alzheimer's & dementia, 2010-07, Vol.6 (4S_Part_6), p.S187-S188

2010

Volltextzugriff (PDF)

F2‐02‐04: Hippocampal Atrophy and Lateral Ventricle Enlargement in Parkinson's Disease Subjects With Mild Cognitive Impairment

Alzheimer's & dementia, 2010-07, Vol.6 (4S_Part_19), p.e2-e3

2010

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(42)

Sprache

Englisch
(41)
Norwegisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Neurology
(15)
Medicin Och Hälsovetenskap
(11)
Alzheimer's Disease
(10)
Biological And Medical Sciences
(10)
Humans
(10)
Neurosciences & Neurology
(10)
Female
(9)
Male
(9)
Aged
(8)
Psychiatry
(8)
Medical Sciences
(7)
Neurosciences
(7)
Dementia
(6)
Alzheimer Disease - Cerebrospinal Fluid
(5)
Amyloid Beta-Peptides - Cerebrospinal Fluid
(5)
Biomarkers - Cerebrospinal Fluid
(5)
Cerebrospinal Fluid
(5)
Clinical Neurology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Glycan analysis of erythropoiesis-stimulating agents

Loss of muscarinic M4 receptors in hippocampus of Alzheimer patients

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease : Clinical and Neurochemical Correlates

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment

CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study

Inhibition of acetylcholine muscarinic M1 receptor function by the M1‐selective ligand muscarinic toxin 7 (MT‐7)

Identification of Novel α-Synuclein Isoforms in Human Brain Tissue by using an Online NanoLC-ESI-FTICR-MS Method

CSF amyloid beta 38 as a novel diagnostic marker for dementia with Lewy bodies

CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies

Inhibition of acetylcholine muscarinic M 1 receptor function by the M 1 ‐selective ligand muscarinic toxin 7 (MT‐7)

The first World Health Organization International Standard for infliximab products: A step towards maintaining harmonized biological activity

Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease

Dynamin protein in stroke and vascular dementia

Loss of muscarinic M 4 receptors in hippocampus of Alzheimer patients

Snake toxins with high selectivity for subtypes of muscarinic acetylcholine receptors

P2‐052: sAPP‐α and sApp‐β levels in Alzheimer's disease, Lewy body and Parkinson's disease dementia patients and their correlation with clinical diagnosis

sAPP-α and sApp-β levels in Alzheimer's disease, Lewy body and Parkinson's disease dementia patients and their correlation with clinical diagnosis

CSF amyloid 38 as a novel diagnostic marker for dementia with Lewy bodies

Inflammatory mediators in the frontal lobe of patients with mixed and vascular dementia

CSF amyloid- and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study

Identification of Novel [alpha]-Synuclein Isoforms in Human Brain Tissue by using an Online NanoLC-ESI-FTICR-MS Method

Biomarkers in spinal fluid of patients with dementia

Biomarkører i spinalvæske ved demens

P1‐049: Hippocampal atrophy and lateral ventricle enlargement in Parkinson's disease subjects with mild cognitive impairment

F2‐02‐04: Hippocampal Atrophy and Lateral Ventricle Enlargement in Parkinson's Disease Subjects With Mild Cognitive Impairment

Suchergebnisse filtern